NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 86 filers reported holding NEXTCURE INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,900 | -28.3% | 10,000 | 0.0% | 0.00% | – |
Q2 2023 | $18,000 | +21.6% | 10,000 | 0.0% | 0.00% | – |
Q1 2023 | $14,800 | +5.0% | 10,000 | 0.0% | 0.00% | – |
Q4 2022 | $14,100 | -49.6% | 10,000 | 0.0% | 0.00% | – |
Q3 2022 | $28,000 | -40.4% | 10,000 | 0.0% | 0.00% | – |
Q2 2022 | $47,000 | -4.1% | 10,000 | 0.0% | 0.00% | – |
Q1 2022 | $49,000 | -18.3% | 10,000 | 0.0% | 0.00% | – |
Q4 2021 | $60,000 | -87.7% | 10,000 | -83.6% | 0.00% | – |
Q2 2021 | $489,000 | -50.2% | 60,870 | -37.9% | 0.00% | – |
Q1 2021 | $982,000 | -6.1% | 98,088 | +2.3% | 0.00% | – |
Q4 2020 | $1,046,000 | +33.9% | 95,887 | +8.2% | 0.00% | – |
Q3 2020 | $781,000 | -53.1% | 88,644 | +14.2% | 0.00% | -100.0% |
Q2 2020 | $1,665,000 | -35.2% | 77,626 | +12.0% | 0.00% | -50.0% |
Q1 2020 | $2,569,000 | -32.6% | 69,291 | +2.3% | 0.00% | 0.0% |
Q4 2019 | $3,814,000 | +344.0% | 67,705 | +143.2% | 0.00% | +100.0% |
Q3 2019 | $859,000 | +122.5% | 27,835 | +8.1% | 0.00% | – |
Q2 2019 | $386,000 | – | 25,746 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 2,671,856 | $16,031,000 | 0.94% |
SILVERARC CAPITAL MANAGEMENT, LLC | 193,012 | $1,158,000 | 0.47% |
DAFNA Capital Management LLC | 187,696 | $1,126,000 | 0.28% |
Sio Capital Management, LLC | 130,000 | $780,000 | 0.24% |
Orbimed Advisors | 2,711,013 | $16,266,000 | 0.21% |
Long Focus Capital Management, LLC | 225,000 | $1,350,000 | 0.18% |
Lombard Odier Asset Management (Switzerland) SA | 407,291 | $2,444,000 | 0.16% |
Ikarian Capital, LLC | 134,055 | $804,000 | 0.12% |
Minerva Advisors LLC | 31,713 | $190,000 | 0.11% |
Anson Funds Management LP | 115,328 | $692,000 | 0.07% |